The E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradationMingyang Cheng, Yan Zeng|Cell Death and Differentiation|2024Cited by 8
ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiotaMingyang Cheng, Xin Cao|mBio|2024Cited by 6
E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradationMingyang Cheng, Yan Zeng|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0